BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38291897)

  • 1. Therapeutic high-dose vitamin D for vitamin D-deficient severe COVID-19 disease: randomized, double-blind, placebo-controlled study (SHADE-S).
    Singh A; Rastogi A; Puri GD; Ganesh V; Naik NB; Kajal K; Kahlon S; Soni SL; Kaloria N; Saini K; Hazarika A; Mahajan V; Singla K; Bhadada S; Soni V
    J Public Health (Oxf); 2024 May; 46(2):256-266. PubMed ID: 38291897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).
    Rastogi A; Bhansali A; Khare N; Suri V; Yaddanapudi N; Sachdeva N; Puri GD; Malhotra P
    Postgrad Med J; 2022 Feb; 98(1156):87-90. PubMed ID: 33184146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
    Murai IH; Fernandes AL; Sales LP; Pinto AJ; Goessler KF; Duran CSC; Silva CBR; Franco AS; Macedo MB; Dalmolin HHH; Baggio J; Balbi GGM; Reis BZ; Antonangelo L; Caparbo VF; Gualano B; Pereira RMR
    JAMA; 2021 Mar; 325(11):1053-1060. PubMed ID: 33595634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL).
    Mariani J; Tajer C; Antonietti L; Inserra F; Ferder L; Manucha W
    Trials; 2021 Feb; 22(1):111. PubMed ID: 33522946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.
    Annweiler C; Beaudenon M; Gautier J; Gonsard J; Boucher S; Chapelet G; Darsonval A; Fougère B; Guérin O; Houvet M; Ménager P; Roubaud-Baudron C; Tchalla A; Souberbielle JC; Riou J; Parot-Schinkel E; Célarier T;
    PLoS Med; 2022 May; 19(5):e1003999. PubMed ID: 35639792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
    Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
    Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial.
    Sabico S; Enani MA; Sheshah E; Aljohani NJ; Aldisi DA; Alotaibi NH; Alshingetti N; Alomar SY; Alnaami AM; Amer OE; Hussain SD; Al-Daghri NM
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial.
    Forno E; Bacharier LB; Phipatanakul W; Guilbert TW; Cabana MD; Ross K; Covar R; Gern JE; Rosser FJ; Blatter J; Durrani S; Han YY; Wisniewski SR; Celedón JC
    JAMA; 2020 Aug; 324(8):752-760. PubMed ID: 32840597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study).
    Amrein K; Parekh D; Westphal S; Preiser JC; Berghold A; Riedl R; Eller P; Schellongowski P; Thickett D; Meybohm P;
    BMJ Open; 2019 Nov; 9(11):e031083. PubMed ID: 31722941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study : A Randomized Clinical Trial.
    Scragg R; Stewart AW; Waayer D; Lawes CMM; Toop L; Sluyter J; Murphy J; Khaw KT; Camargo CA
    JAMA Cardiol; 2017 Jun; 2(6):608-616. PubMed ID: 28384800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial.
    Annweiler C; Beaudenon M; Gautier J; Simon R; Dubée V; Gonsard J; Parot-Schinkel E;
    Trials; 2020 Dec; 21(1):1031. PubMed ID: 33371905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early High-Dose Vitamin D
    ; Ginde AA; Brower RG; Caterino JM; Finck L; Banner-Goodspeed VM; Grissom CK; Hayden D; Hough CL; Hyzy RC; Khan A; Levitt JE; Park PK; Ringwood N; Rivers EP; Self WH; Shapiro NI; Thompson BT; Yealy DM; Talmor D
    N Engl J Med; 2019 Dec; 381(26):2529-2540. PubMed ID: 31826336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial.
    Beigmohammadi MT; Bitarafan S; Hoseindokht A; Abdollahi A; Amoozadeh L; Mahmoodi Ali Abadi M; Foroumandi M
    Trials; 2020 Jul; 21(1):614. PubMed ID: 32631405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study.
    Amrein K; Sourij H; Wagner G; Holl A; Pieber TR; Smolle KH; Stojakovic T; Schnedl C; Dobnig H
    Crit Care; 2011; 15(2):R104. PubMed ID: 21443793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial.
    Amrein K; Schnedl C; Holl A; Riedl R; Christopher KB; Pachler C; Urbanic Purkart T; Waltensdorfer A; Münch A; Warnkross H; Stojakovic T; Bisping E; Toller W; Smolle KH; Berghold A; Pieber TR; Dobnig H
    JAMA; 2014 Oct; 312(15):1520-30. PubMed ID: 25268295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
    Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
    J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D Insufficiency and Deficiency and Mortality from Respiratory Diseases in a Cohort of Older Adults: Potential for Limiting the Death Toll during and beyond the COVID-19 Pandemic?
    Brenner H; Holleczek B; Schöttker B
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32824839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial.
    Martineau AR; James WY; Hooper RL; Barnes NC; Jolliffe DA; Greiller CL; Islam K; McLaughlin D; Bhowmik A; Timms PM; Rajakulasingam RK; Rowe M; Venton TR; Choudhury AB; Simcock DE; Wilks M; Degun A; Sadique Z; Monteiro WR; Corrigan CJ; Hawrylowicz CM; Griffiths CJ
    Lancet Respir Med; 2015 Feb; 3(2):120-130. PubMed ID: 25476069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.